Skip to content
Clinical Trials – home

Szpital św. Anny w Miechowie

Verified siteinfo

Poland Ul. Szpitalna 3, 32-200 Miechow, Poland

  • 1 trial recruiting
  • Arteriosclerosis · Cardiac failure · Dyslipidaemia
  • Adult patients

About Specializations

Szpital św. Anny w Miechowie in Miechow, Poland specialises in clinical trials of conditions such as Arteriosclerosis, Cardiac failure, Dyslipidaemia, Heart failure with reduced ejection fraction, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for atherosclerotic cardiovascular disease. This condition, characterized by the narrowing of arteries due to plaque buildup, poses significant health risks.

  • Major Adverse Cardiovascular Events (MACE)
  • Non-fatal Myocardial Infarction
  • Non-fatal Stroke
  • Coronary Revascularization

Through cutting-edge research, the center aims to reduce the incidence of these critical events, enhancing patient outcomes and advancing the field of cardiovascular medicine.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Szpitalna 332-200 MiechowPoland
Recruiting now
1 trial
Conditions studied
4
Partner status
Verified site

More sites in MiechowPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Omecamtiv mecarbil
  • Sponsor:Cytokinetics Inc.

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.